Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OmniComm Systems has announced that it is providing electronic data capture software and services for a Phase II trial in breast cancer 1/2 and hereditary nonpolyposis colon cancer patients sponsored by Systems Medicine.
Subscribe to our email newsletter
Systems Medicine (SML) initially began its relationship with OmniComm through OmniComm’s CRO preferred program and then selected OmniComm as its electronic data capture (EDC) vendor of choice for its Phase II study.
Stephen Johnson, COO of OmniComm, said: “Research organizations are looking at EDC as a strategic imperative to help maximize their investments in today’s highly competitive clinical research environment.
“OmniComm is privileged to be partnering with companies like SML that are delivering cutting edge cancer treatments to the marketplace. It gives us great satisfaction to know that our TrialMaster EDC solution helps to speed up that process.”